Fight against cancer around the Mediterranean area: "Many hands make light work!".

[1]  J. Daoud,et al.  Nasopharyngeal cancer (NPC) around the Mediterranean area: standard of care. , 2012, Critical reviews in oncology/hematology.

[2]  Arome.  Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties. , 2011, Critical reviews in oncology/hematology.

[3]  P. Levine,et al.  Inflammatory breast cancer in Tunisia , 2010, Cancer.

[4]  A. Ghorbel,et al.  Le carcinome nasopharyngé en Afrique du Nord et dans le Sud-Est asiatique : entre similitude et différence , 2010 .

[5]  S. Rosso,et al.  New data tells us more about cancer incidence in North Africa. , 2010, European journal of cancer.

[6]  R. Zanetti,et al.  [What are we learning from the new data on cancer incidence in North Africa]. , 2010, Epidemiologia & Prevenzione.

[7]  M. Hsairi,et al.  [Breast cancer in Tunisia: epidemiologic characteristics and trends in incidence]. , 2009, La Tunisie medicale.

[8]  S. Remadi,et al.  Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients. , 2009, Archives of medical research.

[9]  J. Zell,et al.  Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry , 2009, Breast Cancer Research.

[10]  F. de Longueville,et al.  Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences. , 2008, Cancer genomics & proteomics.

[11]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[12]  Y. Bignon,et al.  BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases , 2008, International journal of medical sciences.

[13]  T. Messai,et al.  Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study. , 2008, Bulletin du cancer.

[14]  H. Boussen,et al.  Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. , 2008, Seminars in oncology.

[15]  A. Benider,et al.  Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries , 2007, International journal of cancer.

[16]  Wh Sit,et al.  Cancer Genomics & Proteomics , 2007 .

[17]  A. Ben Abdelaziz,et al.  [Bibliometric profile of Tunisians medicals publications indexed in Medline from 2000 to 2003 part 2: social relevance]. , 2007, La Tunisie medicale.

[18]  H. Adami,et al.  The Enigmatic Epidemiology of Nasopharyngeal Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[19]  S. Devesa,et al.  Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. , 2005, Journal of the National Cancer Institute.

[20]  S. Tucker,et al.  Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center. , 2005, International journal of radiation oncology, biology, physics.

[21]  N. Toumi,et al.  Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. , 2003, European journal of cancer.

[22]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[23]  P. Levine,et al.  Epidemiologic features of rapidly progressing breast cancer in Tunisia , 1980, Cancer.